The U.S. Food and Drug Administration, to assist in its mission to protect and promote the public health, uses 50 committees and panels to obtain independent expert advice on scientific, technical, and policy matters. The public and Congress regularly show interest in these advisory committees (ACs), especially the screening for conflicts of interest and the use of waivers for some conflicts. Although the agency has taken a variety of steps to increase transparency and predictability of its ACs, FDA continues to seek opportunities to assess its advisory committee program for future improvement efforts.

Advisory committee reports published prior to 2016 can be found in the FDA Archive

Research and Reports

• FDA-TRACK Advisory Committees
• Fiscal Year 2016 Annual Report on FDA Advisory Committee Vacancies and Public Disclosures
• Fiscal Year 2017 Annual Report on FDA Advisory Committee Vacancies and Public Disclosures
• Fiscal Year 2018 Annual Report on FDA Advisory Committee Vacancies and Public Disclosures
• Fiscal Year 2019 Annual Report on FDA Advisory Committee Vacancies and Public Disclosures